Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase

Jeffrey B. Cheng, Michael A. Levine, Norman H. Bell, David J. Mangelsdorf, David W. Russell

Research output: Contribution to journalArticle

433 Citations (Scopus)

Abstract

The synthesis of bioactive vitamin D requires hydroxylation at the 1α and 25 positions by cytochrome P450 enzymes in the kidney and liver, respectively. The mitochondrial enzyme CYP27B1 catalyzes 1α-hydroxylation in the kidney but the identity of the hepatic 25-hydroxylase has remained unclear for >30 years. We previously identified the microsomal CYP2R1 protein as a potential candidate for the liver vitamin D 25-hydroxylase based on the enzyme's biochemical properties, conservation, and expression pattern. Here, we report a molecular analysis of a patient with low circulating levels of 25-hydroxyvitamin D and classic symptoms of vitamin D deficiency. This individual was found to be homozygous for a transition mutation in exon 2 of the CYP2R1 gene on chromosome 11p15.2. The inherited mutation caused the substitution of a proline for an evolutionarily conserved leucine at amino acid 99 in the CYP2R1 protein and eliminated vitamin D 25-hydroxylase enzyme activity. These data identify CYP2R1 as a biologically relevant vitamin D 25-hydroxylase and reveal the molecular basis of a human genetic disease, selective 25-hydroxyvitamin D deficiency.

Original languageEnglish (US)
Pages (from-to)7711-7715
Number of pages5
JournalProceedings of the National Academy of Sciences of the United States of America
Volume101
Issue number20
DOIs
StatePublished - May 18 2004

Fingerprint

Medical Genetics
Mixed Function Oxygenases
Vitamin D
Enzymes
Hydroxylation
Cytochrome P-450 Enzyme System
Liver
25-Hydroxyvitamin D3 1-alpha-Hydroxylase
Kidney
Mutation
Inborn Genetic Diseases
Vitamin D Deficiency
Proline
Leucine
Exons
Proteins
Chromosomes
Amino Acids
Genes
25-hydroxyvitamin D

ASJC Scopus subject areas

  • Genetics
  • General

Cite this

Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. / Cheng, Jeffrey B.; Levine, Michael A.; Bell, Norman H.; Mangelsdorf, David J.; Russell, David W.

In: Proceedings of the National Academy of Sciences of the United States of America, Vol. 101, No. 20, 18.05.2004, p. 7711-7715.

Research output: Contribution to journalArticle

@article{6d5387e826494ed1a70922b4bf24b818,
title = "Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase",
abstract = "The synthesis of bioactive vitamin D requires hydroxylation at the 1α and 25 positions by cytochrome P450 enzymes in the kidney and liver, respectively. The mitochondrial enzyme CYP27B1 catalyzes 1α-hydroxylation in the kidney but the identity of the hepatic 25-hydroxylase has remained unclear for >30 years. We previously identified the microsomal CYP2R1 protein as a potential candidate for the liver vitamin D 25-hydroxylase based on the enzyme's biochemical properties, conservation, and expression pattern. Here, we report a molecular analysis of a patient with low circulating levels of 25-hydroxyvitamin D and classic symptoms of vitamin D deficiency. This individual was found to be homozygous for a transition mutation in exon 2 of the CYP2R1 gene on chromosome 11p15.2. The inherited mutation caused the substitution of a proline for an evolutionarily conserved leucine at amino acid 99 in the CYP2R1 protein and eliminated vitamin D 25-hydroxylase enzyme activity. These data identify CYP2R1 as a biologically relevant vitamin D 25-hydroxylase and reveal the molecular basis of a human genetic disease, selective 25-hydroxyvitamin D deficiency.",
author = "Cheng, {Jeffrey B.} and Levine, {Michael A.} and Bell, {Norman H.} and Mangelsdorf, {David J.} and Russell, {David W.}",
year = "2004",
month = "5",
day = "18",
doi = "10.1073/pnas.0402490101",
language = "English (US)",
volume = "101",
pages = "7711--7715",
journal = "Proceedings of the National Academy of Sciences of the United States of America",
issn = "0027-8424",
number = "20",

}

TY - JOUR

T1 - Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase

AU - Cheng, Jeffrey B.

AU - Levine, Michael A.

AU - Bell, Norman H.

AU - Mangelsdorf, David J.

AU - Russell, David W.

PY - 2004/5/18

Y1 - 2004/5/18

N2 - The synthesis of bioactive vitamin D requires hydroxylation at the 1α and 25 positions by cytochrome P450 enzymes in the kidney and liver, respectively. The mitochondrial enzyme CYP27B1 catalyzes 1α-hydroxylation in the kidney but the identity of the hepatic 25-hydroxylase has remained unclear for >30 years. We previously identified the microsomal CYP2R1 protein as a potential candidate for the liver vitamin D 25-hydroxylase based on the enzyme's biochemical properties, conservation, and expression pattern. Here, we report a molecular analysis of a patient with low circulating levels of 25-hydroxyvitamin D and classic symptoms of vitamin D deficiency. This individual was found to be homozygous for a transition mutation in exon 2 of the CYP2R1 gene on chromosome 11p15.2. The inherited mutation caused the substitution of a proline for an evolutionarily conserved leucine at amino acid 99 in the CYP2R1 protein and eliminated vitamin D 25-hydroxylase enzyme activity. These data identify CYP2R1 as a biologically relevant vitamin D 25-hydroxylase and reveal the molecular basis of a human genetic disease, selective 25-hydroxyvitamin D deficiency.

AB - The synthesis of bioactive vitamin D requires hydroxylation at the 1α and 25 positions by cytochrome P450 enzymes in the kidney and liver, respectively. The mitochondrial enzyme CYP27B1 catalyzes 1α-hydroxylation in the kidney but the identity of the hepatic 25-hydroxylase has remained unclear for >30 years. We previously identified the microsomal CYP2R1 protein as a potential candidate for the liver vitamin D 25-hydroxylase based on the enzyme's biochemical properties, conservation, and expression pattern. Here, we report a molecular analysis of a patient with low circulating levels of 25-hydroxyvitamin D and classic symptoms of vitamin D deficiency. This individual was found to be homozygous for a transition mutation in exon 2 of the CYP2R1 gene on chromosome 11p15.2. The inherited mutation caused the substitution of a proline for an evolutionarily conserved leucine at amino acid 99 in the CYP2R1 protein and eliminated vitamin D 25-hydroxylase enzyme activity. These data identify CYP2R1 as a biologically relevant vitamin D 25-hydroxylase and reveal the molecular basis of a human genetic disease, selective 25-hydroxyvitamin D deficiency.

UR - http://www.scopus.com/inward/record.url?scp=2442699046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=2442699046&partnerID=8YFLogxK

U2 - 10.1073/pnas.0402490101

DO - 10.1073/pnas.0402490101

M3 - Article

C2 - 15128933

AN - SCOPUS:2442699046

VL - 101

SP - 7711

EP - 7715

JO - Proceedings of the National Academy of Sciences of the United States of America

JF - Proceedings of the National Academy of Sciences of the United States of America

SN - 0027-8424

IS - 20

ER -